MCID: PRL016
MIFTS: 13

Proliferative Type Fibrocystic Change of Breast

Categories: Cancer diseases

Aliases & Classifications for Proliferative Type Fibrocystic Change of Breast

MalaCards integrated aliases for Proliferative Type Fibrocystic Change of Breast:

Name: Proliferative Type Fibrocystic Change of Breast 12 15
Fibrocystic Disease, Proliferative Type with Atypia 12
Fibrocystic Change, Proliferative Type with Atypia 12
Proliferating Lesion of the Breast Without Atypia 12
Proliferating Lesion of Breast Without Atypia 12
Breast Fibrocystic Change, Proliferative Type 73
Proliferative Fibrocystic Change 12

Classifications:



External Ids:

Disease Ontology 12 DOID:3274
NCIt 50 C8365
SNOMED-CT 68 35813005

Summaries for Proliferative Type Fibrocystic Change of Breast

MalaCards based summary : Proliferative Type Fibrocystic Change of Breast, also known as fibrocystic disease, proliferative type with atypia, is related to non-proliferative fibrocystic change of the breast. An important gene associated with Proliferative Type Fibrocystic Change of Breast is GSTO1 (Glutathione S-Transferase Omega 1). The drugs Lovastatin and Niacin have been mentioned in the context of this disorder.

Related Diseases for Proliferative Type Fibrocystic Change of Breast

Diseases related to Proliferative Type Fibrocystic Change of Breast via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 non-proliferative fibrocystic change of the breast 12.4

Symptoms & Phenotypes for Proliferative Type Fibrocystic Change of Breast

Drugs & Therapeutics for Proliferative Type Fibrocystic Change of Breast

Drugs for Proliferative Type Fibrocystic Change of Breast (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 12)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lovastatin Approved, Investigational Phase 2 75330-75-5 53232
2
Niacin Approved, Investigational, Nutraceutical Phase 2 59-67-6 938
3
Nicotinamide Approved, Investigational, Nutraceutical Phase 2 98-92-0 936
4 Anticholesteremic Agents Phase 2
5 Antimetabolites Phase 2
6 Dihydromevinolin Phase 2
7 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 2
8 Hypolipidemic Agents Phase 2
9 L 647318 Phase 2
10 Lipid Regulating Agents Phase 2
11 Nicotinic Acids Phase 2
12 Vitamin B3 Nutraceutical Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention Terminated NCT00285857 Phase 2 Lovastatin
2 Nuclear Morphology of Breast Cells in Ductal Lavage Completed NCT00259597
3 Prolactin Receptor and Breast Diseases Completed NCT00842465

Search NIH Clinical Center for Proliferative Type Fibrocystic Change of Breast

Genetic Tests for Proliferative Type Fibrocystic Change of Breast

Anatomical Context for Proliferative Type Fibrocystic Change of Breast

Publications for Proliferative Type Fibrocystic Change of Breast

Variations for Proliferative Type Fibrocystic Change of Breast

Expression for Proliferative Type Fibrocystic Change of Breast

Search GEO for disease gene expression data for Proliferative Type Fibrocystic Change of Breast.

Pathways for Proliferative Type Fibrocystic Change of Breast

GO Terms for Proliferative Type Fibrocystic Change of Breast

Sources for Proliferative Type Fibrocystic Change of Breast

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....